Fulcrum Therapeutics, Inc. FULC
3.69 USD -0.02 (-0.54%)
Regular-session close
3.68 -0.01 -0.27%
After hours · Nov 20, 4:07 PM ET
3.68 Day range 3.73
3.14 52-week range 14.60
- YTD
- -67.37%
- 1 year
- -66.64%
Discussion (4)
New CRISPR/Cas9 patent issued to Carribou Bio $CRBU
$CRBU
Take a look at Caribou Biosciences.
Leader in CRISPR Gene editing. Cure to all diseases.
Founded by Nobel winner Jennifer Doudna and CEO Rachel Haurwitz.
Market cap 1.3 Billion.
They have 14,453,932 shares of Intellia (NTLA). Worth $2.5 Billion alone. Check out filings:
https://www.sec.gov/edgar/browse/?CIK=1619856&owner=exclude
They have about $500 Million in cash from recent IPO.
Listen to The Code Breaker by Walter Isaacson on Audible. https://www.audible.com/pd?asin=179711705X&source_code=ASSORAP0511160006
Check out patents:
Working on cure for cancer.
This has potential for x 1000
Do your own due diligence.
Good luck
